StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Johnson & Johnson (JNJ) PT Lowered to $170 at BofA Securities
April 17, 2024 5:12 AM
BofA Securities analyst Geoff Meacham lowered the price target on Johnson & Johnson (NYSE: JNJ) to $170.00 (from $180.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Johnson & Johnson (JNJ) PT Lowered to $175 at RBC Capital
April 17, 2024 7:05 AM
Johnson & Johnson (JNJ) PT Lowered to $155 at Stifel
April 16, 2024 3:31 PM
Form 8-K/A JOHNSON & JOHNSON For: Apr 16
April 16, 2024 12:17 PM
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
April 16, 2024 10:46 AM
Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
April 16, 2024 9:01 AM
Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
April 16, 2024 7:57 AM
Form 8-K JOHNSON & JOHNSON For: Apr 16
April 16, 2024 7:07 AM
Johnson & Johnson (JNJ) posts mixed results, narrows full-year guidance
April 16, 2024 6:45 AM
Johnson & Johnson (JNJ) Raises Quarterly Dividend 4.2% to $1.24; 3.4% Yield
April 16, 2024 6:27 AM
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
April 16, 2024 6:25 AM
J&J's medical device sales fall short, cancer drugs seen growing
April 16, 2024 6:22 AM
Johnson & Johnson (JNJ) Tops Q1 EPS by 7c, Revenue Slightly Misses
April 16, 2024 6:21 AM
Johnson & Johnson Reports Q1 2024 Results
April 16, 2024 6:20 AM
Quarterly corporate earnings, Chinese growth, UK wages - what's moving markets
April 16, 2024 5:12 AM
Johnson & Johnson (JNJ) call put ratio 1.7 calls to 1 put options update
April 15, 2024 11:08 AM
